Chilton Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$10.7M |
| 2 |
American Express
AXP
|
+$10.6M |
| 3 |
Biogen
BIIB
|
+$10.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$9.8M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$9.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMC
FMC
|
+$15.9M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$9.38M |
| 3 |
Criteo
CRTO
|
+$6.59M |
| 4 |
3D Systems Corp
DDD
|
+$6.36M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 25.82% |
| 2 | Healthcare | 15.92% |
| 3 | Consumer Discretionary | 8.29% |
| 4 | Industrials | 7.38% |
| 5 | Communication Services | 5.98% |
Similar funds
Chilton Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Chilton Capital Management held 163 positions worth $1.06B, up 6.6% from $996M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Chilton Capital Management deployed $92.3M of net new capital in Q2 2015, opening 9 new positions and adding to 70 existing holdings. Its largest new stake was Biogen: 25,304 shares worth $10.2M.
By sector, the portfolio is most concentrated in Real Estate at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Du Pont De Nemours E I, an estimated $9.38M trimmed.
- Chilton Capital Management's largest Q2 2015 buy was Biogen: 25,304 shares worth $10.2M.
- Chilton Capital Management added most to Celgene Corp in Q2 2015, an estimated $10.7M increase.
- Chilton Capital Management's biggest Q2 2015 reduction was Du Pont De Nemours E I, cutting an estimated $9.38M.
- Chilton Capital Management fully exited FMC in Q2 2015, selling an estimated $15.9M.
- Chilton Capital Management's ten largest holdings make up 24% of its $1.06B portfolio in Q2 2015.
- Chilton Capital Management opened 9 new positions and closed 10 in Q2 2015.
- Chilton Capital Management's portfolio value rose 6.6% quarter-over-quarter to $1.06B.
Based on Chilton Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.